Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $19.5 million.

  • Healthequity's Accounts Payables rose 8884.27% to $19.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $19.5 million, marking a year-over-year increase of 8884.27%. This contributed to the annual value of $14.4 million for FY2025, which is 1926.75% up from last year.
  • Per Healthequity's latest filing, its Accounts Payables stood at $19.5 million for Q4 2025, which was up 8884.27% from $9.6 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Accounts Payables registered a high of $27.5 million during Q1 2022, and its lowest value of $1.6 million during Q1 2021.
  • In the last 5 years, Healthequity's Accounts Payables had a median value of $13.4 million in 2023 and averaged $12.8 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 5989.07% in 2021, then soared by 160638.17% in 2022.
  • Healthequity's Accounts Payables (Quarter) stood at $5.2 million in 2021, then soared by 202.1% to $15.8 million in 2022, then decreased by 15.29% to $13.4 million in 2023, then decreased by 22.86% to $10.4 million in 2024, then skyrocketed by 88.84% to $19.5 million in 2025.
  • Its Accounts Payables stands at $19.5 million for Q4 2025, versus $9.6 million for Q3 2025 and $13.5 million for Q2 2025.